| Dr Kay Mimaki, PHD | |
|
3611 Motor Ave Ste 240, Los Angeles, CA 90034-5887 | |
| (310) 421-8171 | |
| Not Available |
| Full Name | Dr Kay Mimaki |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 3611 Motor Ave Ste 240, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104966308 | NPI | - | NPPES |
| 11569035 | Other | CA | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY18375 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kay Mimaki, PHD 21810 Normandie Ave, Torrance, CA 90502-2047 Ph: (949) 616-0703 | Dr Kay Mimaki, PHD 3611 Motor Ave Ste 240, Los Angeles, CA 90034-5887 Ph: (310) 421-8171 |
News Archive
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults.
Insulating houses can significantly improve health and reduce days off work and school, according to a new study in this week's British Medical Journal.
A team of researchers led by Maryse Bouchard, adjunct professor at the Center for Interdisciplinary Research in Biology, Health, Environment and Society (CINBIOSE) of the Universit du Qu-bec Montr-al and a researcher at Sainte Justine University Hospital, and Donna Mergler, professor emerita in the Department of Biological Sciences and a member of CINBIOSE, recently completed a study showing that children exposed to high concentrations of manganese in drinking water performed worse on tests of intellectual functioning than children with lower exposures.
› Verified 9 days ago
Dr. Jennie M. Mathess, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 840 N Avenue 66, Los Angeles, CA 90042 Phone: 626-395-7100 | |
Dr. Dennis S. Klos, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1554 S Sepulveda Blvd, Suite 211, Los Angeles, CA 90025 Phone: 310-476-5277 | |
Dr. Karen Siscoe, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 450 Bauchet St, Los Angeles, CA 90012 Phone: 213-473-6530 | |
Dr. Kara Taguchi, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 550 S Vermont Ave, Adult Systems Of Care, 12th Floor, Los Angeles, CA 90020 Phone: 213-305-2999 Fax: 213-381-5497 | |
Dr. Kara Lynn Hart, PSY,D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11500 W Olympic Blvd, Suite 500, Los Angeles, CA 90064 Phone: 310-871-7825 Fax: 310-478-6698 | |
Molly Cevasco, PH.D., BCBA Psychologist Medicare: Medicare Enrolled Practice Location: 4650 W Sunset Blvd, Ms #53, Los Angeles, CA 90027 Phone: 323-361-3849 | |
Dr. Adam Vogel, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 621 S Virgil Ave, #300, Los Angeles, CA 90005 Phone: 213-368-5400 |